Submission for OMB Review; Comment Request, 12733-12734 [2016-05291]
Download as PDF
12733
Federal Register / Vol. 81, No. 47 / Thursday, March 10, 2016 / Notices
There will be a number of hazards
included in each image. The participant
will be asked to search for and find the
hazards. During the study, all 62
participants will be asked to search
pictures. The participants will wear a
light weight eye-tracking system so that
eye-movements can be collected and
search patterns can be mapped during
respondent to complete. All 62
respondents will then complete the Risk
Assessment Measure (time to complete,
20 minutes), the Risk Propensity Scale
(time to complete, 6 minutes), the Mine
Specific Risk Tolerance Measure (time
to complete, 6 minutes), and the Openended Questions (time to complete, 30
minutes).
analysis to determine differences based
on level of experience. Identification
accuracy will also be collected to
determine whether level of experience
affects the number of hazards identified.
After the laboratory study is complete,
all 62 respondents will complete the
demographic questionnaire. This should
take approximately six minutes for each
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Mine Employee ...............................................
Safety Professional .........................................
Student ............................................................
Mine Employee ...............................................
Safety Professional .........................................
Student ............................................................
Mine Employee ...............................................
Safety Professional .........................................
Student ............................................................
Mine Employee ...............................................
Safety Professional .........................................
Student ............................................................
Mine Employee ...............................................
Safety Professional .........................................
Student ............................................................
Mine Employee ...............................................
Safety Professional .........................................
Student ............................................................
Mine Employee ...............................................
Safety Professional .........................................
Student ............................................................
Prescreening Questionnaire ...........................
.........................................................................
.........................................................................
Demographic Questionnaire ..........................
.........................................................................
.........................................................................
Experimental Task .........................................
.........................................................................
.........................................................................
Risk Assessment Measure ............................
.........................................................................
.........................................................................
Risk Propensity Scale ....................................
.........................................................................
.........................................................................
Mine Specific Risk Tolerance Measure .........
.........................................................................
.........................................................................
Open Ended Questions ..................................
.........................................................................
.........................................................................
Leroy A. Richardson,
Chief, Information Collection Review Office
Office of Scientific Integrity Office of the
Associate Director for Science Office of the
Director Centers for Disease Control and
Prevention.
[FR Doc. 2016–05358 Filed 3–9–16; 8:45 am]
BILLING CODE 4163–18–P
Number
responses per
respondent
Number of
respondents
Type of respondent
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: ANA Project Impact Assessment
Survey.
OMB No.: 0970–0379.
Description: The information
collected by the Project Impact
Assessment Survey is needed for two
main reasons: (1) To collect crucial
information required to report on the
Administration for Native Americans’
(ANA) established Government
Performance and Results Act (GPRA)
23
10
10
15
8
8
15
8
8
15
8
8
15
8
8
15
8
8
15
8
8
Average
burden per
response
(in hours)
1
15/60
1
6/60
1
1
1
20/60
1
6/60
1
6/60
1
30/60
measures, and (2) to properly abide by
ANA’s congressionally-mandated
statute (42 United States Code 2991 et
seq.) found within the Native American
Programs Act of 1974, as amended,
which states that ANA will evaluate
projects assisted through ANA grant
dollars ‘‘including evaluations that
describe and measure the impact of
such projects, their effectiveness in
achieving stated goals, their impact on
related programs, and their structure
and mechanisms for delivery of
services.’’ The information collected
with this survey will fulfill ANA’s
statutory requirement and will also
serve as an important planning and
performance tool for ANA.
Respondents
mstockstill on DSK4VPTVN1PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
ANA Project Impact Assessment Survey ........................................................
85
1
6
510
Estimated Total Annual Burden Hours .....................................................
........................
........................
........................
510
VerDate Sep<11>2014
17:55 Mar 09, 2016
Jkt 238001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\10MRN1.SGM
10MRN1
12734
Federal Register / Vol. 81, No. 47 / Thursday, March 10, 2016 / Notices
Additional Information
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research
and Evaluation, 330 C Street SW.,
Washington, DC 20201. Attention
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2016–05291 Filed 3–9–16; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0319]
Agency Information Collection
Activities; Comment Request;
Guidance for Industry and Food and
Drug Administration Staff on Dear
Health Care Provider Letters:
Improving Communication of
Important Safety Information
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection associated
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:55 Mar 09, 2016
Jkt 238001
with the guidance for industry and FDA
staff entitled ‘‘Dear Health Care Provider
Letters: Improving Communication of
Important Safety Information.’’ This
guidance offers specific
recommendations to industry on the
content and format of Dear Health Care
Provider (DHCP) letters. These letters
are sent by manufacturers or distributors
to health care providers to communicate
an important drug warning, a change in
prescribing information, or a correction
of misinformation in prescription drug
promotional labeling or advertising.
This guidance provides
recommendations on when to use a
DHCP letter, the types of information to
include in the DHCP letter, how to
organize the information so that it is
communicated effectively to health care
providers, and formatting techniques to
make the information more accessible.
DATES: Submit either electronic or
written comments on the collection of
information by May 9, 2016.
ADDRESSES: You may submit comments
as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2010–D–0319 for Guidance for Industry
and Food and Drug Administration Staff
on Dear Health Care Provider Letters:
Improving Communication of Important
Safety Information. Received comments
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION’’. The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Division of Dockets
Management. If you do not wish your
name and contact information to be
made publicly available, you can
provide this information on the cover
sheet and not in the body of your
comments and you must identify this
information as ‘‘confidential.’’ Any
information marked as ‘‘confidential’’
will not be disclosed except in
accordance with 21 CFR 10.20 and other
applicable disclosure law. For more
information about FDA’s posting of
comments to public dockets, see 80 FR
56469, September 18, 2015, or access
the information at: https://www.fda.gov/
regulatoryinformation/dockets/
default.htm.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
E:\FR\FM\10MRN1.SGM
10MRN1
Agencies
[Federal Register Volume 81, Number 47 (Thursday, March 10, 2016)]
[Notices]
[Pages 12733-12734]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05291]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: ANA Project Impact Assessment Survey.
OMB No.: 0970-0379.
Description: The information collected by the Project Impact
Assessment Survey is needed for two main reasons: (1) To collect
crucial information required to report on the Administration for Native
Americans' (ANA) established Government Performance and Results Act
(GPRA) measures, and (2) to properly abide by ANA's congressionally-
mandated statute (42 United States Code 2991 et seq.) found within the
Native American Programs Act of 1974, as amended, which states that ANA
will evaluate projects assisted through ANA grant dollars ``including
evaluations that describe and measure the impact of such projects,
their effectiveness in achieving stated goals, their impact on related
programs, and their structure and mechanisms for delivery of
services.'' The information collected with this survey will fulfill
ANA's statutory requirement and will also serve as an important
planning and performance tool for ANA.
Respondents
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average
Instrument Number of responses per burden hours Total burden
respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
ANA Project Impact Assessment Survey............ 85 1 6 510
---------------
Estimated Total Annual Burden Hours......... .............. .............. .............. 510
----------------------------------------------------------------------------------------------------------------
[[Page 12734]]
Additional Information
Copies of the proposed collection may be obtained by writing to the
Administration for Children and Families, Office of Planning, Research
and Evaluation, 330 C Street SW., Washington, DC 20201. Attention
Reports Clearance Officer. All requests should be identified by the
title of the information collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment
OMB is required to make a decision concerning the collection of
information between 30 and 60 days after publication of this document
in the Federal Register. Therefore, a comment is best assured of having
its full effect if OMB receives it within 30 days of publication.
Written comments and recommendations for the proposed information
collection should be sent directly to the following: Office of
Management and Budget, Paperwork Reduction Project, Email:
OIRA_SUBMISSION@OMB.EOP.GOV, Attn: Desk Officer for the Administration
for Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2016-05291 Filed 3-9-16; 8:45 am]
BILLING CODE 4184-01-P